Ayala Hubert

8.9k total citations · 1 hit paper
88 papers, 4.1k citations indexed

About

Ayala Hubert is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ayala Hubert has authored 88 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 23 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ayala Hubert's work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Genomics and Diagnostics (19 papers) and Genetic factors in colorectal cancer (18 papers). Ayala Hubert is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Cancer Genomics and Diagnostics (19 papers) and Genetic factors in colorectal cancer (18 papers). Ayala Hubert collaborates with scholars based in Israel, United States and United Kingdom. Ayala Hubert's co-authors include Tamar Peretz, Salomon M. Stemmer, Bella Kaufman, Georgeta Fried, Judith Balmañà, Michael Friedländer, Susan M. Domchek, Ronnie Shapira‐Frommer, M. William Audeh and Niklas Loman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Ayala Hubert

86 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

2014 1.2k citations Bella Kaufman, Ayala Hubert et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayala Hubert Israel	27	2.3k	1.8k	1.1k	739	512	88	4.1k
David S.P. Tan Singapore	37	2.5k 1.1×	2.2k 1.2×	1.5k 1.4×	664 0.9×	563 1.1×	181	5.1k
Annette Hasenburg Germany	38	2.3k 1.0×	886 0.5×	1.1k 1.0×	906 1.2×	718 1.4×	260	4.9k
Ingo B. Runnebaum Germany	36	1.7k 0.7×	1.4k 0.8×	972 0.9×	574 0.8×	384 0.8×	183	4.9k
Anne Hamilton Australia	29	1.9k 0.8×	1.4k 0.8×	569 0.5×	412 0.6×	450 0.9×	72	3.1k
Denice Tsao‐Wei United States	33	2.1k 0.9×	1.9k 1.0×	716 0.7×	264 0.4×	919 1.8×	116	4.7k
Joanne Ngeow Singapore	34	988 0.4×	1.6k 0.9×	719 0.7×	994 1.3×	494 1.0×	147	4.0k
Andy Ryan United Kingdom	29	712 0.3×	1.2k 0.7×	888 0.8×	512 0.7×	341 0.7×	99	3.0k
He-Jing Wang United States	28	2.6k 1.1×	1.3k 0.7×	791 0.7×	255 0.3×	416 0.8×	36	4.4k
G. Bruce Mann Australia	37	2.3k 1.0×	1.5k 0.9×	1.4k 1.3×	543 0.7×	670 1.3×	185	5.2k
Carolyn Y. Muller United States	35	972 0.4×	1.2k 0.7×	504 0.5×	363 0.5×	378 0.7×	104	3.4k

Countries citing papers authored by Ayala Hubert

Since Specialization

Citations

This map shows the geographic impact of Ayala Hubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayala Hubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayala Hubert more than expected).

Fields of papers citing papers by Ayala Hubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayala Hubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayala Hubert. The network helps show where Ayala Hubert may publish in the future.

Co-authorship network of co-authors of Ayala Hubert

This figure shows the co-authorship network connecting the top 25 collaborators of Ayala Hubert. A scholar is included among the top collaborators of Ayala Hubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayala Hubert. Ayala Hubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hubert, Ayala, Sofia Man, Ravit Geva, et al.. (2024). Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data. ESMO Open. 9(8). 103648–103648. 1 indexed citations

Hubert, Ayala, et al.. (2024). Stereotactic body radiotherapy compared to conventionally fractionated radiotherapy for locally advanced or oligometastatic pancreatic cancer.. Journal of Clinical Oncology. 42(3_suppl). 677–677.

Beharier, Ofer, et al.. (2023). A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine. Communications Biology. 6(1). 1157–1157. 20 indexed citations

Brenner, Baruch, Ayala Hubert, Sofia Man, et al.. (2023). Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). 3620–3620.

Furth, Noa, Ekaterina N. Andreishcheva, Daniel Jones, et al.. (2022). Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nature Biotechnology. 41(2). 212–221. 56 indexed citations

Lavie, Ofer, David Edelman, Tally Levy, et al.. (2017). A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Archives of Gynecology and Obstetrics. 295(3). 751–761. 44 indexed citations

Halpern, Naama, Yael Goldberg, Luna Kadouri, et al.. (2017). Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis. OncoTargets and Therapy. Volume 10. 1889–1896. 17 indexed citations

Rottenberg, Yakir, Navah Z. Ratzon, Miri Cohen, et al.. (2016). Unemployment risk at 2 and 4 years following colorectal cancer diagnosis: a population based study. European Journal of Cancer. 69. 70–76. 11 indexed citations

Cohen, Jonathan, et al.. (2015). Retrospective Study of the Predictive Value of Target Now in Systemic Therapy for Metastatic Colorectal and Gastric Carcinomas.. PubMed. 17(10). 612–5. 1 indexed citations

10.

Paluch–Shimon, Shani, Addie Dvir, Luna Kadouri, et al.. (2015). Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Research and Treatment. 155(1). 133–138. 17 indexed citations

11.

Goldberg, Yael, Naama Halpern, Ayala Hubert, et al.. (2015). Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure. Cancer Genetics. 208(12). 621–624. 48 indexed citations

12.

Kanterman, Julia, Moshe Sade-Feldman, Moshe Biton, et al.. (2014). Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes. Cancer Research. 74(21). 6022–6035. 139 indexed citations

13.

Tahover, Esther, Ayala Hubert, Mark Temper, et al.. (2014). An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group. Targeted Oncology. 10(1). 55–63. 18 indexed citations

14.

Hanna, Nader, Patricia Ohana, Fred M. Konikoff, et al.. (2012). Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Therapy. 19(6). 374–381. 113 indexed citations

15.

Goldberg, Yael, Rinnat M. Porat, Inbal Kedar, et al.. (2009). An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Familial Cancer. 9(2). 141–150. 21 indexed citations

16.

Goldzweig, Gil, Elisabeth Andritsch, Ayala Hubert, et al.. (2008). How relevant is marital status and gender variables in coping with colorectal cancer? A sample of middle‐aged and older cancer survivors. Psycho-Oncology. 18(8). 866–874. 89 indexed citations

17.

Rennert, Hanna, Dani Bercovich, Ayala Hubert, et al.. (2002). A Novel Founder Mutation in the RNASEL Gene, 471delAAAG, Is Associated with Prostate Cancer in Ashkenazi Jews. The American Journal of Human Genetics. 71(4). 981–984. 96 indexed citations

18.

Lotem, Michal, Ayala Hubert, Olga Lyass, et al.. (2000). Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin. Archives of Dermatology. 136(12). 1475–80. 156 indexed citations

19.

Lyass, Olga, et al.. (1998). Cisplatin-induced non-convulsive encephalopathy. Anti-Cancer Drugs. 9(1). 100–104. 27 indexed citations

20.

Oren, Ran, G. Zajicek, Yoram Maaravi, et al.. (1997). Methimazole Slows Hepatocyte Streaming in Rats. Digestive Diseases and Sciences. 42(7). 1433–1437. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact